Alzheimers Disease International- The International Federation Of

Organization Overview

Alzheimers Disease International- The International Federation Of is located in Lincolnshire, IL. The organization was established in 1993. According to its NTEE Classification (G83) the organization is classified as: Alzheimers Disease, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 06/2022, Alzheimers Disease International- The International Federation Of employed 12 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alzheimers Disease International- The International Federation Of is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 06/2022, Alzheimers Disease International- The International Federation Of generated $2.1m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 0.2% each year. All expenses for the organization totaled $2.0m during the year ending 06/2022. While expenses have increased by 0.1% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2022

Describe the Organization's Mission:

Part 3 - Line 1

TO BUILD & STRENGTHEN ALZHEIMER ASSOCIATIONS & RAISE AWARENESS ABOUT DEMENTIA WORLDWIDE.

Describe the Organization's Program Activity:

Part 3 - Line 4a

ADI HOSTED ITS CONFERENCE IN LONDON, UK IN JUNE 2022. OVER 1,200 DELEGATES FROM OVER 120 COUNTRIES PARTICIPATED INCLUDING PEOPLE LIVING WITH DEMENTIA, CAREGIVERS, RESEARCHERS, CLINICIANS, AS WELL AS OTHER STAFF AND VOLUNTEERS OF ALZHEIMER AND DEMENTIA ASSOCIATIONS. IT WAS THE FIRST TIME THAT IT WAS OFFERED IN A HYBRID FORMAT WITH BOTH IN-PERSON AND VIRTUAL SESSIONS. THE CONFERENCE THEME 'NEW HORIZONS IN DEMENTIA: BUILDING ON HOPE', CONTINUED BUILDING UPON THE MOMENTUM OF NEW KNOWLEDGE, RESEARCH AND IDEAS, WHICH ULTIMATELY INTEND TO IMPROVE THE LIVES OF PEOPLE LIVING WITH DEMENTIA AND THEIR FAMILIES.


A THREE-DAY ALZHEIMER UNIVERSITY FOR EMERGING ASSOCIATIONS WAS HELD VIRTUALLY IN OCTOBER 2021 WITH PARTICIPANTS FROM 8 COUNTRIES. A POLICY ALZHEIMER UNIVERSITY WAS HELD VIRTUALLY IN MARCH 2022 WITH PARTICIPANTS FROM 5 COUNTRIES. 6 WEBINARS FOR MEMBERS WERE HELD WITH PARTICIPANTS FROM 37 COUNTRIES INCLUDING MEDIA TRAINING, NATIONAL DEMENTIA PLANS AND CATCH-UPS FOR EXCHANGE OF IDEAS AND EXPERIENCES. ADI PUBLISHED ONLINE MASTERCLASSES ON LEADERSHIP AND GOVERNANCE, AND THE ASSOCIATION EVALUATION AND DEVELOPMENT FRAMEWORK. ADI ALSO OFFERS ONE-TO-ONE SUPPORT AND ADVICE TO ASSOCIATIONS.


WORLD ALZHEIMER'S MONTH 2021 SAW 111 COUNTRIES PARTICIPATING, 45 MILLION SOCIAL MEDIA IMPRESSIONS OF THE HASHTAGS AND 461 PIECES OF TRADITIONAL MEDIA COVERAGE INCLUDING BBC WORLD SERVICE, NBC, WALL STREET JOURNAL AND ASTRO AWANI. THE WORLD ALZHEIMER REPORT 2021, ENTITLED 'JOURNEY THROUGH THE DIAGNOSIS OF DEMENTIA', INCLUDES OVER 50 ESSAYS FROM LEADING EXPERTS FROM AROUND THE WORLD ON THE MULTIFACETED ISSUE OF DIAGNOSIS AND FINDINGS FROM GLOBAL SURVEYS WHICH RECEIVED RESPONSES FROM 1,111 CLINICIANS, 2,325 PEOPLE WITH DEMENTIA AND CARERS, AND 100 NATIONAL ALZHEIMER ASSOCIATIONS. ADI ALSO LAUNCHED THE REPORTS 'FROM PLAN TO IMPACT IV AND CONTRIBUTED TO OTHER PUBLICATIONS. ADI PUBLISHES A REGULAR "GLOBAL PERSPECTIVE" NEWSLETTER AND OTHER EDUCATIONAL PUBLICATIONS.


IN MARCH 2022, THE 4-YEAR STRIDE (STRENGTHENING RESPONSES TO DEMENTIA IN DEVELOPING COUNTRIES) PROJECT ENDED. ADI WROTE A POLICY GUIDE INCORPORATING NEW METHODOLOGY ON VIGNETTES, QUALITATIVE HEALTH ECONOMIC DATA, AND SIMULATION AND COST MODELLING. ADI CONDUCTED WORKSHOPS ON DEVELOPING POLICY MESSAGING AND WRITING POLICY BRIEFS. WE WORKED TO GATHER EVIDENCE TO APPLY FOR ANTI-DEMENTIA DRUGS TO BE ADDED TO WHO'S ESSENTIAL MEDICINES LIST (EML). WE COLLABORATED IN OTHER RESEARCH PROJECTS TO PROMOTE THE INVOLVEMENT OF ALZHEIMER ASSOCIATIONS PARTICULARLY FROM LOW AND MIDDLE INCOME COUNTRIES.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Paola Barbarino
CEO
$151,502
Christopher Lynch
Deputy CEO
$106,324
Dale Goldhawk
Chair
$0
Andrew Ketteringham
Vice Chair
$0
John Grosvenor
Treasurer
$0
Alireza Atri
Director
$0

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$465,598
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$900,953
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$1,366,551
Total Program Service Revenue$751,123
Investment income $514
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $2,118,188

Grants Recieved

Over the last fiscal year, we have identified 1 grants that Alzheimers Disease International- The International Federation Of has recieved totaling $10,000.

Awarding OrganizationAmount
Goldman Sachs Philanthropy Fund

New York, NY

PURPOSE: MEDICAL / PUBLIC SERVICES

$10,000
View Grant Recipient Profile

Create an account to unlock the data you need.

or